These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3665630)

  • 1. Serum concentrations and adverse effects of chloramphenicol in pediatric patients.
    Nahata MC
    Chemotherapy; 1987; 33(5):322-7. PubMed ID: 3665630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloramphenicol serum concentration falls during chloramphenicol succinate dosing.
    Nahata MC; Powell DA
    Clin Pharmacol Ther; 1983 Mar; 33(3):308-13. PubMed ID: 6825386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of predictability of chloramphenicol toxicity in paediatric patients.
    Nahata MC
    J Clin Pharm Ther; 1989 Aug; 14(4):297-303. PubMed ID: 2793954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative chloramphenicol detection in serum and cerebrospinal fluid of infants with bacterial meningitis].
    Köhler E; Klaer U; Meyer FP; Walther H
    Kinderarztl Prax; 1991; 59(1-2):38-43. PubMed ID: 2056660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic interactions among chloramphenicol, phenytoin and phenobarbital.
    Krasinski K; Kusmiesz H; Nelson JD
    Pediatr Infect Dis; 1982; 1(4):232-5. PubMed ID: 7177912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of chloramphenicol sodium succinate after intramuscular administration in children.
    Shann F; Linnemann V; Mackenzie A; Barker J; Gratten M; Crinis N
    N Engl J Med; 1985 Aug; 313(7):410-4. PubMed ID: 4022068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Need for the determination of chloramphenicol levels in the treatment of bacterial-purulent meningitis with chloramphenicol succinate in infants and small children].
    Forster J; Hufschmidt C; Niederhoff H; Künzer W
    Monatsschr Kinderheilkd; 1985 Apr; 133(4):209-13. PubMed ID: 4000136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of chloramphenicol therapy in the newborn infant.
    Rajchgot P; Prober CG; Soldin S; Golas C; Good F; Harding E; MacLeod S
    J Pediatr; 1982 Dec; 101(6):1018-21. PubMed ID: 7143156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of two chloramphenicol preparations in children: sodium succinate (iv) and palmitate (oral) esters.
    Pickering LK; Hoecker JL; Kramer WG; Kohl S; Cleary TG
    J Pediatr; 1980 Apr; 96(4):757-61. PubMed ID: 6987361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of chloramphenicol in pediatric therapy.
    Kauffman RE
    Prog Clin Biol Res; 1983; 135():315-27. PubMed ID: 6364159
    [No Abstract]   [Full Text] [Related]  

  • 11. Chloramphenicol sodium succinate in the horse: serum, synovial, peritoneal, and urine concentrations after single-dose intravenous administration.
    Brown MP; Kelly RH; Gronwall RR; Stover SM
    Am J Vet Res; 1984 Mar; 45(3):578-80. PubMed ID: 6711989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Optimum dose study of cefozopran in the pediatric field].
    Fujii R; Sunakawa K; Sato Y; Yokota T; Yoshimura K; Kondoh Y; Kawaoi Y; Terashima I; Meguro H; Niinou K; Toyonaga Y; Ishihara T; Iwai N; Nakamura H; Kuno K; Miyajima Y; Sakurai M; Itoh M; Kawasaki H; Suga S; Kamiya H; Fujiwara T; Inui T; Taniguchi K; Nakayama M
    Jpn J Antibiot; 1996 Jul; 49(7):663-77. PubMed ID: 8828069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative bioavailability of intravenous chloramphenicol succinate and oral chloramphenicol palmitate in infants and children.
    Kauffman RE; Thirumoorthi MC; Buckley JA; Aravind MK; Dajani AS
    J Pediatr; 1981 Dec; 99(6):963-7. PubMed ID: 7310593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloramphenicol: what we have learned in the last decade.
    Feder HM
    South Med J; 1986 Sep; 79(9):1129-34. PubMed ID: 3529436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloramphenicol toxicity in neonates: its incidence and prevention.
    Mulhall A; de Louvois J; Hurley R
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1424-7. PubMed ID: 6416440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and clinical efficacy of imipenem/cilastatin sodium in neonates].
    Azagami S; Kusumoto Y; Oikawa T; Osano M; Shiro H; Shirai Y; Nakamura M
    Jpn J Antibiot; 1988 Nov; 41(11):1704-14. PubMed ID: 3210302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine monitoring of gentamicin serum concentrations in pediatric patients with normal renal function is unnecessary.
    Logsdon BA; Phelps SJ
    Ann Pharmacother; 1997 Dec; 31(12):1514-8. PubMed ID: 9416390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloramphenicol dosage and pharmacokinetics in infants and children.
    Burckart GJ; Barrett FF; Della Valle R; Meyer MC
    J Clin Pharmacol; 1983; 23(2-3):106-12. PubMed ID: 6853742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetic and clinical studies on panipenem/betamipron in the pediatric field].
    Toyonaga Y; Yamori K; Hatakeyama K; Kawamura K; Seo K; Hori M
    Jpn J Antibiot; 1992 Mar; 45(3):329-51. PubMed ID: 1512930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloramphenicol succinate kinetics in infants and young children.
    Sack CM; Koup JR; Opheim KE; Neeley N; Smith AL
    Pediatr Pharmacol (New York); 1982; 2(2):93-103. PubMed ID: 12760401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.